Podcast Episodes
Back to SearchCirculation 8 2026 Semaglutide and the Inflammatory Pathways to Cardiovascular Health
This study explores how the medication semaglutide reduces the risk of major heart-related events by targeting chronic inflammation in patients with …
1 month, 1 week ago
JAMA August 2026 Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors
This study evaluates whether methadone or buprenorphine-naloxone is more effective at preventing mortality among high-risk individuals who have recen…
1 month, 2 weeks ago
JAMA August 2026 Arginine Therapy for Sickle Cell Disease Acute Pain Episodes
This clinical trial investigated whether administering intravenous arginine could effectively alleviate the intense pain crises commonly experienced …
1 month, 2 weeks ago
JAMA August 2026 Predictive Utility of Coronary Artery Calcium Score Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations
This study examines whether measuring coronary artery calcium (CAC)—a marker of plaque buildup—improves the accuracy of a new medical tool called the…
1 month, 2 weeks ago
NEJM 2026 Survodutide Once Weekly for the Treatment of Adults with Obesity
This study evaluates the effectiveness of survodutide, a novel dual-action medication that targets two different metabolic receptors to promote weigh…
1 month, 2 weeks ago
NEJM August 2026 Azithromycin for Preschoolers with Wheezing in the Emergency Department
This medical study investigated whether the antibiotic azithromycin could alleviate moderate-to-severe wheezing in preschool-aged children, a conditi…
1 month, 2 weeks ago
NEJM August 2026 Carbocisteine or Hypertonic Saline for Acute Respiratory Failure
This clinical study investigated whether two common medications, carbocisteine and hypertonic saline, could reduce the amount of time critically ill …
1 month, 2 weeks ago
NEJM August 2026 Selpercatinib in Early-Stage RET Fusion–Positive Non–Small-Cell Lung Cancer
This clinical study investigates the effectiveness of selpercatinib, a targeted drug that blocks the RET protein, as a follow-up treatment for patien…
1 month, 3 weeks ago
NEJM August 2026 In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
This study evaluates the clinical effectiveness of VERVE-102, a novel gene-editing treatment designed to combat high cholesterol by permanently alter…
1 month, 3 weeks ago
NEJM August 2026 Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica
This study investigates the efficacy of secukinumab, a monoclonal antibody, as a novel treatment for patients suffering from relapsed polymyalgia rhe…
1 month, 3 weeks ago